MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 104 filers reported holding MERUS N V in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,911 | -74.2% | 802 | -71.2% | 0.00% | – |
| Q2 2023 | $73,197 | +14.6% | 2,780 | -19.9% | 0.00% | – |
| Q1 2023 | $63,848 | +16.9% | 3,470 | -1.7% | 0.00% | – |
| Q4 2022 | $54,609 | -0.7% | 3,530 | +29.4% | 0.00% | – |
| Q3 2022 | $55,000 | -15.4% | 2,727 | -5.5% | 0.00% | – |
| Q2 2022 | $65,000 | -98.0% | 2,885 | -97.6% | 0.00% | -100.0% |
| Q1 2022 | $3,203,000 | +23.3% | 121,157 | +48.3% | 0.00% | +100.0% |
| Q4 2021 | $2,597,000 | +0.6% | 81,678 | -30.4% | 0.00% | -50.0% |
| Q3 2021 | $2,581,000 | +1473.8% | 117,297 | +1407.9% | 0.00% | – |
| Q2 2021 | $164,000 | +3180.0% | 7,779 | +3238.6% | 0.00% | – |
| Q1 2021 | $5,000 | +25.0% | 233 | +15.3% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 202 | +21.7% | 0.00% | – |
| Q3 2020 | $2,000 | -95.6% | 166 | -94.1% | 0.00% | – |
| Q2 2020 | $45,000 | +32.4% | 2,817 | +40.8% | 0.00% | – |
| Q3 2016 | $34,000 | +112.5% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $16,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |